Background-Adenosine is a potent coronary vasodilator and causes an in
crease of coronary blood flow by activation of A(2A)-adenosine recepto
rs (A(2A)-AdoRs). The purpose of this study was to test the hypothesis
that the high potency of adenosine and adenosine analogues to cause c
oronary vasodilation is explained by the presence of a large A(2A)-Ado
R reserve (''spare receptors''). Methods and Results-A novel, irrevers
ible antagonist of A(2A)-AdoRs was used to inactivate receptors and re
duce the response to agonist. Agonist-induced increases of coronary co
nductance before and after exposure of hearts to the irreversible anta
gonist were compared. Three agonists were studied: hyl)-phenethylamino
-5'-N-ethylcarboxamidoadenosine (CGS21680), adenosine, and 2-chloro-N-
6-cyclopentyladenosine (CCPA). Data were analyzed to determine agonist
K-A (equilibrium dissociation constant) and EC50 values. Values of K-
A for activation of A(2A)-AdoRs by CGS21680, adenosine, and CCPA were
105, 1800, and 2630 nmol/L, respectively. In contrast, values of EC50
for CGS21680, adenosine, and CCPA to increase coronary conductance wer
e 1.5, 85, and 243 nmol/L, respectively. By use of the law of mass act
ion, it was calculated that half-maximal responses to CGS21680, adenos
ine, and CCPA occurred when only 1.3%, 5%, and 9%, respectively, of A(
2A)-AdoRs were occupied by agonist. Conclusions-Receptor reserves for
3 A(2A)-AdoR agonists were large. The receptor reserve for A(2A)-AdoRs
to cause an increase of coronary conductance can explain both the hig
h potency of adenosine to cause coronary vasodilation and the observat
ion that an A(2A)-AdoR agonist can cause coronary vasodilation without
systemic effects.